CPC Biotech has officially launched as a new global brand, bringing together complementary technologies to support critical fluid management across biopharmaceutical and biotechnology applications.

The new brand combines CPC’s established expertise in precision plastic components, aseptic connection technologies and fluid handling solutions with a wider portfolio of proven bioprocessing technologies, including Quattroflow® four-piston diaphragm pumps, SumoFlo® Coriolis mass flow meters, BioPro™ flow measurement systems, sensors and wider flow control solutions.

Together, these capabilities create a broader and more coherent portfolio for critical fluid management, supporting the connection, transfer, measurement and control of sensitive fluids across demanding process environments.

For biopharmaceutical manufacturers and biotechnology organisations, fluid management is a critical part of process performance. Whether working in research, development, scale-up or commercial production, the ability to handle fluids with accuracy, consistency and product integrity is essential. This is especially important across high-value manufacturing applications, including biologics, cell and gene therapies, and wider biotechnology processes.

We are pleased to see this development and look forward to continuing our support for customers across the UK. Many of our customers already know and rely on established technologies such as Quattroflow pumps, SumoFlo meters and BioPro flow measurement systems. The CPC Biotech brand provides a clearer platform for presenting these solutions as part of a wider, joined-up critical fluid management portfolio.

While CPC’s connector and plastic component technologies form an important part of the broader CPC Biotech offering, BPES will continue to focus on providing local technical and commercial support for the pump, flow measurement and fluid control technologies our customers know us for.

As biopharmaceutical and biotechnology manufacturing continues to evolve, the need for reliable, scalable and well-integrated fluid management technologies will only become more important. CPC Biotech brings a stronger, more coherent identity to a portfolio already trusted across critical process applications, and we look forward to supporting UK customers as these technologies continue to develop under the new brand.